findmyKOL

Robert Fintelmann, MD

Basic profile

Midwestern University

ORCIDNone on fileNPI↗
✓ Full record
RegionGlendale, AZ · WestSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL type: RegionalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Robert Fintelmann is an Ophthalmology physician affiliated with Midwestern University. OpenAlex indexes 25 publications with 435 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
25publications

Distinct works indexed by OpenAlex.

435citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5865 W Utopia Rd
Glendale, AZ 853085251

Telephone

623-537-6000

Provider last certified this registry record 29 Jan 2023.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    67.1%
    Corticosteroid45.2%
    Prednisolone Acetate79%Fluorometholone14%Dexamethasone Sodium Phosphate7%
    Part D<11 patients
    Aminoglycoside Antibacterial14.5%
    Neomycin-Polymyxin-Dexameth100%
    Part D≥46 patients

    + 2 more classes in this area

  • Anti-infectives

    26.5%
    Fluoroquinolone Antibacterial18.4%
    Moxifloxacin100%
    Part D≥62 patients
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.2%
    Valacyclovir100%
    Part D≥11 patients

    + 1 more class in this area

  • Musculoskeletal

    3.7%
    Nonsteroidal Anti-inflammatory Drug3.7%
    Diclofenac Sodium100%
    Part D≥13 patients
Where care is delivered (Part B)23% facility · 77% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”